IP Library Granted Patent US 10,125,352
Granted Patent B2
US 10,125,352 · App. 15/022,049 · Granted Nov 13, 2018

Method for producing enveloped viruses

Inventor: David Fenard (Mennecy, FR)
Assignee: GENETHON
C12N7/00C07K14/005C12N15/86C12N2740/13022C12N2740/15043C12N2740/15045C12N2740/15051C12N2740/15052C12N2740/16021C12N2740/16043C12N2740/16051C12N2760/20222
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,125,352
App. No.
15/022,049
Granted
Nov 13, 2018
Kind
B2
Abstract

The invention relates to a process for producing enveloped viruses in a mildly acid medium. The processes of the invention are useful for producing and recovering at a large scale enveloped viruses under conditions observing good manufacturing practice (GMP).

Claims (10)

1. A process for producing an enveloped virus comprising cultivating host cells producing said enveloped virus in a mildly acidic culture medium, wherein the enveloped virus is a lentivirus, optionally pseudotyped.

2. The process according to claim 1 , the mildly acidic medium having a pH between 5.8 and 6.2.

3. The process according to claim 1 , the lentivirus being pseudotyped with an envelope protein selected from the VSV-G envelope protein or the GALVTR envelope protein.

4. The process according to claim 1 , the host cell being a HEK293, HEK293T, HEK293FT, Te671, CEM, NIH-3T3, Mpf, or D17 cell.

5. The process according to claim 1 , said process comprising the following steps:

transient transfection of HEK293T cells by means of one or several plasmids coding for the elements required for producing said enveloped vector;

cultivation of said cells in a suitable medium, of which the pH is about 6; and

harvesting the enveloped virus in the culture supernatant.

6. The process according to claim 5 , the cells being transfected by means of four plasmids: one plasmid bearing an expression cassette comprising a lentiviral gagpol gene, one plasmid bearing an expression cassette comprising a lentiviral rev gene, one transfer plasmid comprising an expression cassette of a transgene of interest, comprised between a lentiviral LTR-5′ and a LTR-3′, and one plasmid bearing an expression cassette of envelope glycoprotein(s).

7. The process according to claim 1 , wherein said cells are cultivated in a mildly acid medium 5 to 24 hours after transfection.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 4, 2016
From: FENARD, DAVID
To: GENETHON
Reel/Frame 038451/0689 →
Priority Claims (1)
FR 13 58909 · Sep 16, 2013 · national
Continuity (1)
Related Publication 20160230147A1 · Aug 11, 2016
Cited By (2)
US 12,365,873 US 12,391,960